<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD) has been occasionally reported to be associated with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>From October 1991 to June 1993, four <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients with a previous history of CD but no history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> were referred to our institution </plain></SENT>
<SENT sid="2" pm="."><plain>Three presented <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with a monoblastic proliferation (one AML4 and two AML5) </plain></SENT>
<SENT sid="3" pm="."><plain>Cytogenetic analysis revealed a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype in two patients, an inv(16) in another and a del(11)(q24-25) in the fourth </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, the three patients with AML4/AML5 had not received high doses of <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi>, prior CD therapy ranging from 1 to 4 months <z:chebi fb="3" ids="9334">sulfasalazine</z:chebi> with additional <z:chebi fb="2" ids="2948">azathioprine</z:chebi> in one case </plain></SENT>
</text></document>